HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daiki Oikawa Selected Research

Enzymes

1/2022(+)-Sesamin, a sesame lignan, is a potent inhibitor of gut bacterial tryptophan indole-lyase that is a key enzyme in chronic kidney disease pathogenesis.
12/2021SGLT-1-specific inhibition ameliorates renal failure and alters the gut microbial community in mice with adenine-induced renal failure.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daiki Oikawa Research Topics

Disease

3Inflammation (Inflammations)
09/2022 - 01/2021
2Colorectal Neoplasms (Colorectal Cancer)
09/2022 - 01/2021
2Chronic Renal Insufficiency
01/2022 - 12/2021
1Alcoholism (Alcohol Abuse)
04/2023
1Colitis
09/2022
1Necrosis
09/2022
1Dysbiosis
12/2021
1Type 2 Diabetes Mellitus (MODY)
12/2021
1Diabetic Nephropathies (Diabetic Nephropathy)
12/2021
1Fibrosis (Cirrhosis)
12/2021
1Renal Insufficiency (Renal Failure)
12/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021

Drug/Important Bio-Agent (IBA)

2Ethanol (Ethyl Alcohol)IBA
09/2022 - 01/2021
2EnzymesIBA
01/2022 - 12/2021
1AcetaldehydeIBA
04/2023
1NF-kappa B (NF-kB)IBA
09/2022
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
09/2022
1sesaminolIBA
09/2022
1Interleukin-6 (Interleukin 6)IBA
09/2022
1sesaminIBA
01/2022
1TryptophanaseIBA
01/2022
1LignansIBA
01/2022
1AdenineFDA LinkGeneric
12/2021
1Glucose (Dextrose)FDA LinkGeneric
12/2021
1SodiumIBA
12/2021
1Sulfates (Sulfates, Inorganic)IBA
12/2021
1Tyrosine (L-Tyrosine)FDA Link
12/2021
1Phenol (Carbolic Acid)FDA Link
12/2021
1SGL5213IBA
12/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021
1CytokinesIBA
01/2021

Therapy/Procedure

2Oral Administration
09/2022 - 01/2021